The ATTRibute-CM study's open-label extension showed that acoramidis effectively lowers all-cause mortality in patients with ...

The FDA has granted Fast Track designation to VS-041, an investigational therapy for the treatment of heart failure with preserved ejection fraction.

In an update on nex-z's phase I study, the CRISPR-Cas9 gene therapy stayed the course out to 3 years in an initial 36-person cohort with transthyretin amyloid cardiomyopathy (ATTR-CM). Serum TTR ...

Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers ...

MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular ...

A two-year-old boy died in Dumka allegedly due to delayed treatment at a community health centre after a road accident. The family, along with another cyclist, sustained injuries when their motorcycle ...

Background: Anthracyclines are highly effective, yet cancer therapy-related cardiac dysfunction (CTRCD) and heart failure are known adverse effects. Elevations in hsTnT and NT-proBNP may predict CTRCD ...

When medical school professor Bryant Lin founded the Stanford Center for Asian Health Research and Education, he wanted to advance research on diseases that disproportionately affect Asian populations ...

Harlow's mom told Newsweek that "she would essentially be locked in her body until she passed away," without the treatment. Tropical Storm Melissa update as ...

Former Biden White House press secretary Karine Jean-Pierre unleashed on the Democratic Party in an excerpt from her new memoir, explaining why she decided to become an independent after years as a ...

Former Biden White House press secretary Karine Jean-Pierre unleashed on the Democratic Party in an excerpt from her new memoir, explaining why she decided to become an independent after years as a ...

Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers SOUTH SAN FRANCISCO, Calif., Nov. 10 ...